Fundz

Bio Pact Cellular Transport, Inc. is looking to raise $20,000

Oct 13, 2020over 5 years ago

Target Amount

$20,000

Deadline

Feb 12, 2021

CIK0001797565
File Number007-00115

Issuer ContactFrom SEC filing

Legal nameBioPact Cellular Transport, Inc.
Websitebiopactct.com
Address13477 FITZHUGH ROAD
AUSTIN, TX, 78736

Issuer Information

Issuer

BioPact Cellular Transport, Inc.

Location

13477 fitzhugh road

austin, texas, united states

About

Biopact Cellular Transport (Biopact CT) is a nanoscale biomaterials company using the breakthrough MGMR technology for intracellular delivery.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C/A)
Target Amount$20,000
Securities TypeCommon Stock
StateTX

Campaign Ended

Ended 1945 days ago

View SEC Filing

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.